NCT00784212View on ClinicalTrials.gov

Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Photosensitive Epilepsy
Interventions
DRUG

BGG492

DRUG

BGG492

DRUG

Placebo

Trial Locations (4)

Unknown

Novartis Investigator Site, Bielefeld

Novartis Investigator Site, Kehl-Kork

Novartis Investigator Site, Kiel

Novartis Investigator Site, Radeberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY